Bayesian Capital Management’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,277
Closed -$229K 710
2020
Q3
$229K Buy
+3,277
New +$257K 0.06% 412
2017
Q4
Sell
-5,500
Closed -$324K 775
2017
Q3
$324K Buy
+5,500
New +$328K 0.08% 347
2016
Q4
Sell
-6,400
Closed -$304K 743
2016
Q3
$304K Buy
+6,400
New +$331K 0.2% 193

Other funds holding CONE

Bayesian Capital Management's CONE Position: Q4 2020 in Review

Bayesian Capital Management sold out of CyrusOne Inc Common Stock (CONE) in Q4 2020, closing a stake of 3,277 shares — an estimated $229K sold.

Bayesian Capital Management first reported a position in CONE in Q3 2016 and held it in 3 quarters. The position peaked at $324K in Q3 2017. 412 funds tracked by Wall St. Rank hold CONE as of Q4 2020.

  • Bayesian Capital Management reported no remaining CyrusOne Inc Common Stock position as of Q4 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 3,277 CyrusOne Inc Common Stock shares in Q4 2020, an estimated $229K.
  • Bayesian Capital Management first reported a position in CyrusOne Inc Common Stock in Q3 2016 and held it in 3 quarters.
  • Bayesian Capital Management's CyrusOne Inc Common Stock position peaked at $324K in Q3 2017.
  • 412 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q4 2020.

Based on Bayesian Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.